PUF Ventures Joins the Cannvas Marché Program as First Licensed Producer

Cannvas MedTech (CSE:MTEC) (“Cannvas” or the “Company”), a leading business technology company in the cannabis space, is pleased to announce it has executed an agreement with PUF Ventures Inc. (“PUF”) (CSE:PUF) (Frankfurt: PU3) (OTCPK: PUFXF), a growth-oriented and diversified company focused on the international cannabis industry, to become the first licensed producer to join the recently announced Cannvas Marché, a network of high-tech learning and fulfillment centres across Canada. PUF has secured premiere access to the digital experience screens to be presented in each Cannvas Marché location.

“We share the concerns of leading politicians about the delivery of cannabis and feel by putting education at the forefront of this industry, we can take steps to reduce the risks associated with cannabis,” said Derek Ivany, President and CEO of PUF Ventures Inc. “The concept to provide accessible and unbiased cannabis education to consumers at the point of purchase will be very attractive to large cities like Toronto, Montreal and Vancouver. The timing for the launch of the Cannvas Marché concept could not be better with legalization upon us. I look forward to working with Steve and Shawn and the rest of the team at Cannvas on the rollout of this impressive program to benefit the cannabis industry here in Canada and abroad.”

“I would like to welcome PUF Ventures as the first licensed producer to join our Cannvas Marché program,” said Steve Loutskou, Chief Operating Officer of Cannvas MedTech Inc. “The response to the launch of the new brand and concept has been incredible, as there is a definite lack of quality, unbiased, physician-backed information regarding the potential health benefits of cannabis. We are committed to improving access to cannabis education through a network of locations across the country and are engaged in discussions with various government bodies to accelerate the rollout. We will look to attract other leading licensed producers to join the Cannvas Marché program and contribute to the overall digital experience for customers.”

With city and provincial governments stating concerns regarding the legalization of cannabis and its potential impact on neighbourhood safety and public health, PUF has teamed up with Cannvas to take a proactive approach to solving these issues. Cannvas Marché will improve accessibility to free and unbiased education on deriving the potential benefits of medical and adult-use cannabis, while providing consumers with retail options from leading cannabis brands.

Cannvas is working with top regulators and compliance bodies to begin the first phase of creating a network of this first-of-its-kind public cannabis education and fulfillment centres.
The Company intends to expand the reach of its Cannvas Marché centres to communities across Canada through a licensing model and leverage its strategic partnerships to further integrate the Cannvas.Me platform into existing retail experiences.

Operating under the brand Cannvas Marché, each location will feature digital learning resources, on-site medical and educational staff and a fulfillment program. Hands-on education sessions on a variety of cannabis-related topics will also be featured, but without the usual pressure to purchase or consume. The sessions will be led by a registered health practitioner or certified educator and showcase original physician-backed content created for the Cannvas.Me platform. Visitors can register for free seminars each week or drop in anytime.  The first location is expected to open in Toronto in 2019.

Additionally, the Company announces that it has granted incentive stock options to purchase a total of 1,360,000 common shares at an exercise price of $0.51 per share for a period of five years to certain directors and officers in accordance with the provisions of its stock option plan.

About Cannvas MedTech Inc.

Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted onwww.sedar.com.

Click here to connect with Cannvas MedTech (CSE:MTEC) for an Investor Presentation.